journal article·2023-12-31Open access

Ultrasound-triggered release of miR-199a-3p from liposome nanobubbles for enhanced hepatocellular carcinoma treatment

Xinmin Guo, Jianru Lin, Liwen Pan, Kun He, Zhihui Huang, Jialin Chen, Cuiyan Lin, Baohui Zeng, Sijia Luo, Mengdie Wang

Abstract

This study was aimed to develop an efficient tumour-targeted liposome nanobubbles (LNBs) system using ultrasound-targeted nanobubble destruction for enhanced release and transfection of miRNA-199a-3p in hepatocellular carcinoma (HCC) therapy. The prepared LNBs comprised a polyethylene glycol-modified liposome shell and a perfluoropentane (PFP) core. MiRNA-199a-3p was attached to the nanocomposite surface via electrostatic adsorption, while RGD peptide functionalized the LNBs surface for enhanced HCC cell targeting, namely PFP@miR-RGD-LNBs. The LNBs were spherical with a narrow size distribution. The gene-loaded LNBs effectively condensed miR-199a-3p and protected it from enzymatic degradation. Low-intensity focused ultrasound (LIFU) promoted a fast release of miR-199a-3p from the prepared LNBs, thereby enhancing therapeutic effects. The combined application of PFP@miR-RGD-LNBs and LIFU exhibited a more potent inhibitory effect on HepG2 cells than the other groups, potentially due to LIFU promoting rapid and efficient gene release at the target site and increasing cell membrane permeability. Quantitative reverse transcription-polymerase chain reaction analysis revealed significantly increased mRNA expression levels of key apoptosis markers (Bad, Bax, Caspase-9 and Caspase-3) in the PFP@miR-RGD-LNBs + LIFU group compared to other groups. These findings suggest that the prepared LNBs are highly likely to be promising candidates for further exploration of HCC gene delivery and therapy.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Ultrasound and Hyperthermia Applications · Extracellular vesicles in disease · Photoacoustic and Ultrasonic Imaging

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Ultrasound, Guangzhou Red Cross Hospital of Jinan University, Guangzhou, China

Department of Endocrinology, Guangzhou Red Cross Hospital of Jinan University, Guangzhou, China

Department of Nuclear Medicine, Guangzhou Red Cross Hospital of Jinan University, Guangzhou, China

Funding

2022 Basic and Applied Basic Research Project of Guangzhou Basic Research Plan jointly funded by Municipal Universities · Guangzhou Municipal Health Commission, Western medicine general guidance project

References (33)

Show source-provided references
1. 10.4155/tde-2019-007610.4155/tde-2019-0076 ↗
2. 10.3748/wjg.v12.i38.608510.3748/wjg.v12.i38.6085 ↗
3. 10.3390/cancers1112186510.3390/cancers11121865 ↗
4. 10.1016/j.cell.2009.01.00210.1016/j.cell.2009.01.002 ↗
5. 10.3390/ijms1307844910.3390/ijms13078449 ↗
6. 10.1016/j.ccr.2011.01.00110.1016/j.ccr.2011.01.001 ↗
7. 10.1177/101042831771515510.1177/1010428317715155 ↗
8. 10.1016/j.biopha.2017.01.05810.1016/j.biopha.2017.01.058 ↗
9. 10.1038/onc.2014.25410.1038/onc.2014.254 ↗
10. Paladini L, Fabris L, Bottai G, et al. Targeting microRNAs as key modulators of tumor immune response. J Exp Clin Cancer Res. 2016;35:1–19.10.1186/s13046-016-0375-2 ↗
11. 10.1038/s41389-020-00282-y10.1038/s41389-020-00282-y ↗
12. 10.1016/j.omtn.2022.07.01510.1016/j.omtn.2022.07.015 ↗
13. 10.2174/1566523211313999000310.2174/15665232113139990003 ↗
14. 10.1517/17425247.5.10.112110.1517/17425247.5.10.1121 ↗
15. 10.1016/j.ultrasmedbio.2010.11.01110.1016/j.ultrasmedbio.2010.11.011 ↗
16. 10.1016/j.ultsonch.2021.10580510.1016/j.ultsonch.2021.105805 ↗
17. 10.1080/17425247.2016.119212310.1080/17425247.2016.1192123 ↗
18. 10.1152/ajpheart.01120.200510.1152/ajpheart.01120.2005 ↗
19. 10.1073/pnas.060292110310.1073/pnas.0602921103 ↗
20. 10.1016/j.ijpharm.2021.12141210.1016/j.ijpharm.2021.121412 ↗
21. 10.1016/j.addr.2008.03.00510.1016/j.addr.2008.03.005 ↗
22. 10.1021/am503622510.1021/am5036225 ↗
23. 10.1038/gt.2009.8410.1038/gt.2009.84 ↗
24. 10.3892/mmr.2013.167210.3892/mmr.2013.1672 ↗
25. 10.1002/anie.20020055010.1002/anie.200200550 ↗
26. 10.1055/s-0039-168849210.1055/s-0039-1688492 ↗
27. 10.7150/ntno.4689210.7150/ntno.46892 ↗
28. 10.1039/d0ra06415g10.1039/d0ra06415g ↗
29. 10.1074/jbc.R00000320010.1074/jbc.R000003200 ↗
30. 10.1007/s10989-018-9728-310.1007/s10989-018-9728-3 ↗
31. Zitzmann S, Ehemann V, Schwab M. Arginine-glycine-aspartic acid (RGD)-peptide binds to both tumor and tumor-endothelial cells in vivo. Cancer Res. 2002;62(18):5139–5143.
32. 10.3390/jpm1106057110.3390/jpm11060571 ↗
33. 10.3892/ol.2013.144810.3892/ol.2013.1448 ↗